Document Detail

No Improvement in Survival of Patients with Amyloidosis Associated with Inflammatory Rheumatic Diseases -- Data from the Finnish National Registry for Kidney Diseases.
MedLine Citation:
PMID:  18412307     Owner:  NLM     Status:  Publisher    
OBJECTIVE: To assess the incidence and outcome of renal replacement therapy (RRT) among patients with amyloidosis associated with inflammatory rheumatic diseases. METHODS: Patients with amyloidosis entering RRT from 1987 to 2002 were identified from the Finnish Registry for Kidney Diseases. Five hundred two patients were identified, 80% of whom had amyloidosis associated with an underlying rheumatic disease. They were followed from the time of entering RRT until death or until the end of 2003 using the Finnish national mortality files. RESULTS: During the study period, there was no decline in the number of patients with amyloidosis entering RRT. Mean age of patients with rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) increased significantly from 1987 to 2002 (p < 0.001). Male sex and a diagnosis of JIA indicated an increased risk of mortality. The median survival time after entering RRT was 2.11 years for RA (95% CI 1.93 to 2.69), 2.37 years for ankylosing spondylitis (95% CI 1.11 to 4.31), and 3.05 years for JIA (95% CI 2.19 to 4.23). The 5-year survival rates among patients with the corresponding diagnoses were 18% (95% CI 14% to 23%), 30% (95% CI 14% to 48%), and 27% (95% CI 14% to 41%), respectively. CONCLUSION: No decline was seen in the number of patients with amyloidosis associated with inflammatory rheumatic diseases accepted for RRT, but over the years, the age of patients with RA or JIA entering RRT was seen to increase. The outcome of patients with amyloidosis and endstage renal disease associated with rheumatic diseases remains poor.
Kai Immonen; Patrik Finne; Markku Hakala; Hannu Kautiainen; Tom Pettersson; Carola Grönhagen-Riska
Related Documents :
10569657 - Right atrial appendage thrombosis in atrial fibrillation: its frequency and its clinica...
25024337 - Apathy and apoe4 are associated with reduced bdnf levels in alzheimer's disease.
6213997 - Concanavalin a-induced suppressor cell activity and in vitro immunoglobulin secretion i...
3967977 - Radiation exposure rates near brachytherapy patients containing 137cs sources.
15965927 - How accurate is measuring postvoid residual volume by portable abdominal ultrasound equ...
23223537 - Higher macular volume in patients with ms receiving fingolimod: positive outcome or sid...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2008-4-15
Journal Detail:
Title:  The Journal of rheumatology     Volume:  -     ISSN:  -     ISO Abbreviation:  J. Rheumatol.     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-4-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7501984     Medline TA:  J Rheumatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
From the Departments of Medicine, North-Karelia Central Hospital, Joensuu and Helsinki University Central Hospital, Helsinki; Rheumatism Foundation Hospital, Heinola; and the Department of Musculoskeletal Medicine and Rehabilitation, Medical School, University of Tampere, Tampere, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interf...
Next Document:  HLA-DRB1 alleles and Henoch-Schönlein purpura: susceptibility and severity of disease.